Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Piccin

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Regenerative Medicine|June 28, 2016
Healing of a soft tissue wound of the neck and jaw osteoradionecrosis using platelet gelAndrea Piccin, Angela Maria Di Pierro, Mario Tagnin, et al.
Transfusion|June 29, 2017
Impressive tissue regeneration of severe oral mucositis post stem cell transplantation using cord blood platelet gelAndrea Piccin, Paolo Rebulla, Simonetta Pupella, et al.
American Journal of Hematology|March 11, 2015
Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-upFederico Mosna, Cristina Papayannidis, Giovanni Martinelli, et al.
Annals of Hematology|October 4, 2011
Quality of life in elderly patients with essential thrombocythaemia. An Italian multicentre studyEsther Natalie Oliva, Andrea Piccin, Maria Gabriella Mazzucconi, et al.
Annals of Hematology|February 22, 2012
Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL)Luigi Rigacci, Benedetta Puccini, Sergio Cortelazzo, et al.
British Journal of Haematology|March 5, 2011
Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective studyEmilio Iannitto, Fortunato Morabito, Salvatrice Mancuso, et al.
Haematologica|February 24, 2018
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trialRiccardo Bomben, Simone Ferrero, Tiziana D'Agaro, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 6, 2017
Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemiaAndrea Piccin, Michael Steurer, Clemens Feistritzer, et al.
Internal and Emergency Medicine|January 15, 2015
Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemiaAndrea Piccin, Michael Steurer, Manfred Mitterer, et al.
Haematologica|September 21, 2019
<i>KMT2D</i> mutations and <i>TP53</i> disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL studySimone Ferrero, Davide Rossi, Andrea Rinaldi, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Regenerative Medicine|June 28, 2016
Healing of a soft tissue wound of the neck and jaw osteoradionecrosis using platelet gelAndrea Piccin, Angela Maria Di Pierro, Mario Tagnin, et al.
Transfusion|June 29, 2017
Impressive tissue regeneration of severe oral mucositis post stem cell transplantation using cord blood platelet gelAndrea Piccin, Paolo Rebulla, Simonetta Pupella, et al.
American Journal of Hematology|March 11, 2015
Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-upFederico Mosna, Cristina Papayannidis, Giovanni Martinelli, et al.
Annals of Hematology|October 4, 2011
Quality of life in elderly patients with essential thrombocythaemia. An Italian multicentre studyEsther Natalie Oliva, Andrea Piccin, Maria Gabriella Mazzucconi, et al.
Annals of Hematology|February 22, 2012
Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL)Luigi Rigacci, Benedetta Puccini, Sergio Cortelazzo, et al.
British Journal of Haematology|March 5, 2011
Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective studyEmilio Iannitto, Fortunato Morabito, Salvatrice Mancuso, et al.
Haematologica|February 24, 2018
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trialRiccardo Bomben, Simone Ferrero, Tiziana D'Agaro, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 6, 2017
Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemiaAndrea Piccin, Michael Steurer, Clemens Feistritzer, et al.
Internal and Emergency Medicine|January 15, 2015
Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemiaAndrea Piccin, Michael Steurer, Manfred Mitterer, et al.
Haematologica|September 21, 2019
<i>KMT2D</i> mutations and <i>TP53</i> disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL studySimone Ferrero, Davide Rossi, Andrea Rinaldi, et al.
Pageof 8